Find your next paid study

Wayne State UniversityNCT07222306

~$10 – $750

Actual pay is set by the research site.

Locally Advanced Non-Small Cell Lung Cancer (NSCLC)Metastatic Non-Small Cell Lung Cancer (NSCLC)

A Phase 2, Randomized, Open-label, Study Assessing the Safety, Tolerability and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

The purpose of this study is to assess the safety, tolerability, and efficacy of Imzokitug in combination with Pumitamig and Platinum-Doublet Chemotherapy (PDC…

Bristol-Myers SquibbNCT07680764

~$75 – $3,000

Actual pay is set by the research site.

Nephrotic SyndromeLipodystrophyMetabolic Syndrome+3 more

Prospective Cross-Over Study of the Effects of Meal Macronutrients on Postprandial Lipids

Background: Abnormal fats in the blood can lead to many problems, including heart disease. Researchers want to learn more about how eating meals with differen…

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT07313787

~$75 – $1,800

Actual pay is set by the research site.

Cigarette Smoking-Related Carcinoma

Sensory Evaluation of Cigarettes Claiming Removal of Menthol as a Characterizing Flavor

This clinical trial tests how well current daily smoking adults can identify flavors of cigarettes. Menthol cigarettes account for 31 percent of cigarettes sol…

Roswell Park Cancer InstituteNCT06816459

~$500 – $11,250

Actual pay is set by the research site.

Maternal Cancer Diagnosis and Treatment During Pregnancy:a Registry for Maternal, Fetal, and Neonatal Outcomes With Longitudinal Follow up of Child Development and Maternal Psychological Well Being

The objective of this study is to follow the treatment options offered to pregnant women diagnosed with cancer and study the impact that their treatment or del…

Pregnancy, Cancer, Cancer in Pregnancy, Gestational Breast Cancer, Pregnancy Related

The Cooper Health SystemNCT02749474

~$10 – $750

Actual pay is set by the research site.

Observational

Effectivity of P1821, a Novel Tongue Strengthening and Endurance Enhancing Speech Flow Exercise

The P1821 initiative constitutes an innovative intervention specifically engineered to enhance tongue muscular strength and endurance. The primary objective of…

AnkyloglossiaImpairment of SpeechSlurred Speech

Dream Video LLCNCT07719582

~$10 – $1,050

Actual pay is set by the research site.

Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms

Background: * Endocrine neoplasms (tumors) are among the fastest growing tumors in incidence in the United States. Furthermore, it is often difficult to disti…

Endocrine TumorsThyroid NeoplasmsParathyroid Neoplasms+2 more

National Cancer Institute (NCI)NCT01005654

~$10 – $675

Actual pay is set by the research site.

Environment and Alcohol: A Pilot Study

Background: Alcohol use disorder (AUD) is a chronic disease that causes more than 140,000 US deaths each year. AUD treatment often includes therapy and medica…

Alcohol Use Disorder

National Institute on Drug Abuse (NIDA)NCT06860607

~$500 – $6,750

Actual pay is set by the research site.

A Phase 2/3, Randomized, Open-label, Active-comparator-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Bomedemstat (MK-3543) Versus Best Available Therapy in Participants With Polycythemia Vera Who Have an Inadequate Response to or Are Intolerant to Hydroxyurea

Researchers are looking for new ways to treat polycythemia vera (PV). People with PV may receive treatment to lower the number of red blood cells in the blood,…

Polycythemia Vera

Merck Sharp & Dohme LLCNCT07722611

~$75 – $2,800

Actual pay is set by the research site.

Targeting CD38 With Daratumumab in Primary Antiphospholipid Syndrome: A Phase 1b Dose Escalation Safety Trial (ITN093AI)

The purpose of this study is to see if the study medication, daratumumab, is safe to treat individuals with Anti-Phospholipid Syndrome (APS). Three daratumuma…

Autoimmune Disorders

National Institute of Allergy and Infectious Diseases (NIAID)NCT05671757

~$150 – $2,700

Actual pay is set by the research site.

Glioblastoma (GBM)Newly Diagnosed GlioblastomaGBM+4 more

A Phase 2 Randomized, Multicenter Study to Evaluate the Efficacy and Safety of Silevertinib, an Oral EGFR Inhibitor, in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma With Unmethylated MGMT Promoter and EGFRvIII

The purpose of this study is to see if combining silevertinib with temozolomide after surgery and radiotherapy helps treat newly diagnosed glioblastoma (GBM) b…

Black Diamond Therapeutics, Inc.NCT07326566

~$75 – $2,800

Actual pay is set by the research site.

X-linked Severe Combined Immunodeficiency (XSCID)

Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined Immunodeficiency

This is a Phase I/II non-randomized clinical trial of ex vivo hematopoietic stem cell (HSC) gene transfer treatment for X-linked severe combined immunodeficien…